Please click here to view event photos from previous Faculty of Medicine meetings and the most recent December 20, 2012 meeting
Nezam H. Afdhal
Dr. Afdhal is a Professor of Medicine at the Beth Israel Deaconess Medical Center and has worked in the areas of clinical and translational research for liver fibrosis and hepatitis C. He has pioneered the use of non-invasive tests to stage liver disease and the use of adjuvant hematological support therapy for treatment of hepatitis C. His work has resulted in the clinical utilization of novel FDA approved treatments and devices in liver diseases.Marcus Altfeld
Dr. Altfeld is Professor of Medicine at the Mass General Hospital, and serves as the Director of the Innate Immunity Program at the Ragon Institute of MGH, MIT and Harvard. He is a recognized leader in the studies of NK cell immunity in viral infection. His overall research focus on understanding the role of innate and adaptive immunity in HIV-1 pathogenesis and vaccine design.
Ronnie L. Alterman
Dr. Alterman is Chief of the Division of Neurosurgery at Beth Israel Deaconess Medical Center and Professor of Surgery. He is a leader in the field of stereotactic and functional neurosurgery. His work has focused on improving the outcomes of deep brain stimulation (DBS) surgeries and he has also played a key role in the development of virally-mediated gene therapies for Parkinson’s disease, performing the first ever direct injection of a gene therapy into the substantia nigra in a human.John H. Arnold
Dr. Arnold is Professor of Anaesthesia at Boston Children’s Hospital. His area of clinical and research interest is the use of innovative modes of mechanical ventilation and non-invasive pulmonary imaging to achieve lung protection. His research and publications have focused on high frequency ventilation, partial liquid breathing and electrical impedance changes to quantify lung mechanics non-invasively. He is Medical Director of Respiratory Care/Biomedical Engineering/ECMO at Boston Children’s Hospital.Brian J. Bacskai
Dr. Bacskai is a Professor of Neurology at the Mass General Hospital. He is a leading investigator in the study of Alzheimer’s disease using preclinical research models. He is internationally recognized as a pioneer in the use of state-of-the-art optical imaging approaches to monitor the molecular and cellular events in the living brain, enabling the evaluation of candidate therapies to prevent or reverse progression of disease.Alexander A. Bankier
Dr. Alexander Bankier is Professor of Radiology, Chief of the Cardiothoracic Imaging section and Director of Functional Respiratory Imaging at the Department of Radiology at Beth Israel Deaconess Medical Center. His main research endeavors focus on innovative imaging techniques of chronic obstructive pulmonary disease, pulmonary neoplasms, and airways disease, notably following lung transplantation. As Deputy Editor of the journal RADIOLOGY, he also has a strong interest in medical publishing.Herbert Benson
Dr. Herbert Benson is Professor of Medicine and the Director Emeritus of the Benson-Henry Institute for Mind Body Medicine at the Massachusetts General Hospital. He was the first to define the counterpart of the stress response, the relaxation response, by its physiological, biochemical, behavioral and genomic parameters. His ground-breaking contributions were instrumental in the creation of the discipline of Mind Body Medicine.Deepak L. Bhatt
Dr. Bhatt is Professor of Medicine at Brigham and Women’s Hospital and the VA Boston Healthcare System. He is a leading investigator in cardiovascular care and uses randomized clinical trials and registries to address problems that affect large numbers of patients. His research interests include preventive cardiology, the optimal management of patients with acute coronary syndromes, and advanced techniques in cardiac, cerebral, and peripheral intervention.George L. Blackburn
Dr. George L. Blackburn is Professor of Surgery at Beth Israel Deaconess Medical Center and Associate Director of the Division of Nutrition at Harvard Medical School. He is the Director of the Center for the Study of Nutrition Medicine and Chief of the Nutrition Metabolism Laboratory. His work in the field of nutrition involves basic, clinical and translational research in areas of critical importance to public health.Giles W. L. Boland
Dr. Boland is Professor of Radiology. His seminal work in adrenal and pancreatic imaging has enabled the non-invasive staging of malignant disease within these glands. He also serves as Vice Chair for Business Development at the Mass General Hospital Department of Radiology with Directorships in a number of clinical and business programs and his publications on workflow methodologies have been widely adopted.Vadim Bolshakov
Dr. Bolshakov is a Professor of Psychiatry and the Director of the Cellular Neurobiology Laboratory at McLean Hospital. He is a recognized leader in the study of synaptic mechanisms of learned behaviors. Work in his laboratory has illuminated how the information that is contained in the specific patterns of afferent input activity could be encoded and preserved during learning.Vassiliki A. Boussiotis
As a basic immunologist working on T cell activation and signaling, Dr. Boussiotis’s work on the molecular regulation of T cell immunity and T cell anergy is thought to be a seminal contribution to the literature of T cell responses. She is a Professor of Medicine at the Beth Israel Deaconess Medical Center, serves as a member of the Immunology Executive Committee and the Graduate Education Committee at Harvard Medical School and as an Attending Physician in Hematology-Oncology and Bone Marrow Transplantation.Anna-Liisa Brownell
Dr. Brownell is Professor of Radiology and Director of the MicroPET Core at the Athinoula A. Martinos Biomedical Imaging Center at MGH. Her research comprises development of experimental Nuclear Medicine techniques to investigate physiological and pathophysiological processes by using preclinical models and translating them to human studies. Her latest achievement has been to develop in vivo PET imaging to investigate metabotropic glutamate receptors in different neurological conditions.Carlos Camargo
Dr. Camargo is Professor of Medicine at Massachusetts General Hospital. His research focuses on nutrition and respiratory/allergy disorders, including the role of vitamin D on infectious disease. He also founded and directs the Emergency Medicine Network, an international research collaboration that has completed many studies on respiratory/allergy emergencies and on diverse public health issues.Bartolome R. Celli
Dr. Celli is a Professor of Medicine in the Pulmonary Division of the Brigham and Women’s Hospital. He helped develop the BODE index to predict survival, the first array of gene expression in lung tissue and serum proteomic profiling in patients with chronic obstructive pulmonary disease (COPD). Dr. Celli has been recognize by Science Watch for being one of the most cited scholars in the field of COPD in the world.Talal Chatila
Dr. Chatila has joined Harvard Medical School this year as a Professor of Pediatrics, and Senior Physician at the Division of Immunology, Children’s Hospital Boston. His research, focused on mechanisms of immune regulation, has led to the identification of several novel immunodeficiency and immune dysregulatory diseases in humans. His current studies address cellular and genetic mechanisms governing the establishment of immune tolerance and its breakdown in autoimmune and allergic diseases.
E. Antonio Chiocca
Dr. Chiocca has joined Harvard Medical School from Ohio State University Wexner Medical Center where he was chief of Neurosurgery. He is now Professor of Surgery at Brigham and Women’s Hospital and Neurosurgeon-in-Chief and Head of Neurosurgery. His research program has focused on the biology of malignant gliomas, one of the deadliest cancers in humans, and exploring the use of biological agents as novel glioma therapeutics.James J. Chou
Dr. Chou’s is a Professor of Biological Chemistry and Molecular Pharmacology at Harvard Medical School. His laboratory pushed the envelope of NMR technology to enable structural characterization of membrane proteins in dynamic, non-crystalline states. Their NMR research also contributed to understanding the structural basis of immune receptor assembly in cell membrane as well as the mechanism of T cell receptor signaling across the membrane.
Edmund Cibas
Dr. Cibas is Professor of Pathology at Brigham and Women’s Hospital and a recognized leader in the field of cytopathology. Dr. Cibas established the Fine Needle Aspiration (FNA) Center at BWH, which provides safe and accurate, minimally invasive diagnosis for patients. His leadership role in the Thyroid FNA State of the Science Conference at the National Cancer Institute led to the development and wide adoption, in the U.S. and abroad, of The Bethesda System for Reporting Thyroid Cytopathology.Alan R. Cohen
Dr. Cohen, former chief of pediatric neurological surgery and Surgeon in Chief at Rainbow Babies, has joined Harvard as Neurosurgeon-in-Chief at Children’s Hospital Boston and Professor of Surgery. His research has focused on advancing the discipline of Minimally Invasive Neurosurgery using novel techniques to enhance the safety and efficacy of selected surgical procedures. He serves as a director of the American Board of Neurological Surgery and American Board of Pediatric Neurological Surgery.
Nancy Cook
Dr. Cook is Professor of Medicine at the Brigham and Women’s Hospital. She is a biostatistician whose work on risk predictive modeling has made essential contributions to the field both in its methodology and in its clinical implications. She has also been lead investigator on studies related to the effects of sodium on cardiovascular disease, the results of which have had a significant influence on public policy.Ronald Eisenberg
Dr. Eisenberg is Professor of Radiology and Associate Residency Program Director at the Beth Israel Deaconess Medical Center. Author of more than 20 books in his specialty, including Gastrointestinal Radiology: An Illustrated History; he is also a non-practicing attorney and author of Radiology and the Law. He has been awarded Masters and Doctoral degrees in Jewish Studies from Spertus Institute in Chicago and has published six critically acclaimed books in Jewish studies.Georges El Fakhri
Dr. El Fakhri is Professor of Radiology, Director of the Center for Advanced Radiological Sciences (CARS) and co-Director of the Division of Nuclear Medicine and Molecular Imaging at Massachusetts General Hospital. He is an international expert in quantitative imaging using positron emission tomography (PET-CT, PET-MR). His seminal work in quantitative dual tracer imaging allows differential diagnosis of many neurodegenerative, cardiac and oncologic diseases as well as the objective assessment of response to treatment.Alan N. Engelman
Dr. Engelman is a leading expert on the molecular mechanism of retroviral DNA integration, a key clinical target in the fight against HIV/AIDS. He is a Professor of Medicine at the Dana-Farber Cancer Institute, and his research has elucidated how HIV-1 interacts with chromosomes to effect integration, and how the clinical integrase inhibitors work.Mel B. Feany
Dr. Feany is Professor of Pathology at Brigham and Women’s Hospital. Her laboratory pioneered the development of Drosophila models of common human neurodegenerative disorders, including Parkinson’s and Alzheimer’s disease. The laboratory has subsequently used the models to provide critical insights into the molecular mechanisms underlying neurodegeneration in these diseases.Bruce R. Fischl
Dr. Fischl is Professor of Radiology and Director of the Computational Core at the Athinoula A. Martinos Center for Biomedical Imaging at MGH/Harvard Medical School. His research involves developing algorithms for the automated extraction of information from neuroimaging data, and the use of this data to better diagnose and understand normal and pathological brain structure, function and connectivity. The open source software that has been developed in his lab (FreeSurfer) is in use by tens of thousands of researchers around the world, and has directly improved our understanding of an array of neurologic conditions and pathologies.Steven J. Fishman
Dr. Fishman is Professor of Surgery and Vice-Chair for Clinical Operations of the Department of Surgery at Boston Children’s Hospital, where he is also Co-Director of the Vascular Anomalies Center. He is an international authority on the study and management of vascular tumors and malformations. He is particularly known for having developed innovative treatment strategies and procedures for complex visceral vascular anomalies.Atul A. Gawande
Dr. Gawande is a general and endocrine surgeon at Brigham and Women’s Hospital and has a joint appointment in the Dept. of Health Policy and Management at the Harvard School of Public Health. He is also lead advisor for the World Health Organization’s patient safety programs in surgery and childbirth, and a staff writer for the New Yorker magazine. His research focuses on systems innovations to transform health care safety and cost, and his books (Complications, Better, and The Checklist Manifesto) have been national bestsellers.C. Michael Gibson
Dr. Gibson is Professor of Medicine at the Beth Israel Deaconess Medical Center. A cardiologist by training, Dr. Gibson invented a quantitative measure of coronary artery blood flow and an assessment of myocardial (heart muscle) blood flow and demonstrated the relationship of these measures to survival. He created WikiDoc, a free open source textbook of medicine viewed 150 million times per year.Robert J. Glynn
Dr. Glynn is a Professor of Medicine, and a biostatistician in the Divisions of Preventive Medicine, and Pharmacoepidemiology and Pharmacoeconomics, at Brigham and Women’s Hospital. He has been responsible for the design, interim monitoring, and analysis of numerous multi-center randomized trials, and has led both randomized and observational studies that have clarified the shared and distinct risk factors and possible preventive approaches for venous and arterial thrombosis, including large trials of the impact of aspirin, vitamin E, and statins on the incidence of venous thromboembolism.Marcia B. Goldberg
Dr. Goldberg is Professor of Medicine at Massachusetts General Hospital. Her work has elucidated aspects of basic processes of bacterial cell biology and their implications for bacterial pathogenesis, with emphasis on how bacteria position proteins at specific sites in the bacterial cell and how they secrete proteins across membranes. She also serves as Senior Associate Director of the Harvard-MIT MD PhD Program.Jeffrey A. Golden
Dr. Golden recently joined the faculty from the University of Pennsylvania where he was head of the department of pathology and laboratory medicine at the Children’s Hospital of Pennsylvania. He is now a Professor of Pathology and Head of the Department of Pathology at Brigham and Women’s Hospital and Pathologist-in-chief at the BWH/Faulkner Hospitals. Dr. Golden is nationally and internationally recognized for his multifarious and valuable contributions to the understanding of the molecular basis of the development of the nervous system and pediatric diseases of the nervous system.
Elizabeth Goodman
Dr. Goodman is Director of the Center for Child & Adolescent Health Research and Policy and Professor of Pediatrics at Mass General Hospital. She is a leading scientist studying the psychological and physiological processes through which social hierarchies influence health in adolescents and the transition to adulthood. She pioneered the development of the field of subjective social status research in adolescence and has made important contributions to understanding health disparities, cardiometabolic risk in adolescents and the early developmental origins of adult cardiovascular disease.David Grabowski
Dr. Grabowski is a recognized leader in the study of aging and long-term care. He is a Professor of Health Care Policy at Harvard Medical School, and uses his expertise in health economics to examine the financing, organization, and delivery of services for older individuals. His work on the economic explanations for low nursing home quality is thought to be a critical contribution to the literature.Nathanael S. Gray
Dr. Gray is a Professor Biological Chemistry and Molecular Pharmacology at HMS and the Dana Farber Cancer Institute. His research focuses on the identification, optimization and utilization of new inhibitors of potential anti-cancer targets, and his laboratory utilizes structure-based drug design, medicinal chemistry and biological assays to develop novel small molecules. His laboratory has discovered unique inhibitors of mTor, and other mutant targets of cell signaling pathways which have resulted in new insights into their function and, in several cases, inspired drug discovery efforts.Jennifer S. Haas
Dr. Haas is Professor of Medicine in the Division of General Internal Medicine at Brigham and Women’s Hospital. She is an internationally recognized expert focused on elucidating and reducing disparities in health care and health status, and has directed numerous observational and interventional studies. Her work has been used to promote health care reform at both the state and national level.Mitchel B. Harris
Dr. Harris is Professor of Orthopedic Surgery and the Chief of Brigham and Women’s Orthopaedic Trauma Service as well as an active member of the adult spine service. His passion for these two specialty areas has led to his international reputation as a researcher and educator in the evaluation and management of the spine injured polytrauma victim. He is one of the founding directors of the highly successful BWH-HBS Leadership Program providing managerial training to faculty interested in pursuing leadership roles within the academic medical community.Friedhelm Hildebrandt
This winter Dr. Hildebrandt will be joining Harvard and Boston Children’s Hospital as a Professor of Pediatrics, where he will serves as Chief of the Division of Nephrology. As an Investigator of the Howard Hughes Medical Institute and a faculty member at the University of Michigan, he is an internationally recognized leader in research on the molecular genetics and pathogenesis of kidney diseases. Work in his laboratory has led to the identification and functional characterization of over twenty single-gene disease causes of the kidney and the eye using whole exome approaches.Robert E. Hillman
Dr. Hillman is Professor of Surgery and Co-Director and Research Director of the Center for Laryngeal Surgery and Voice Rehabilitation at Massachusetts General Hospital. He is also Director of Research Programs at the MGH Institute of Health Professions. Dr. Hillman is an internationally recognized leader in the development of innovative approaches for assessing and treating voice and speech disorders. His contributions have earned him the American Speech-Language-Hearing Association’s highest award (Honors) for the significant impact of his work.R. Paul Johnson
Dr. Johnson is a Professor of Medicine at Harvard Medical School, and holds a joint appointment between the New England Primate Research Center, where he serves as Director of the Division of Immunology and Interim Director, and the Massachusetts General Hospital. His research focuses on AIDS immunopathogenesis, innate immunity and identification of mechanisms of protective immunity against lentiviruses.Adam S. Kibel
As a newly appointed member of our faculty, Dr. Kibel serves as Chief of Urologic Surgery at Brigham and Women’s Hospital and Dana-Farber Cancer Institute. Dr. Kibel is Professor of Surgery at Brigham and Women’s Hospital and also the Program Director of the Longwood Area Urology Residency Program. Dr. Kibel’s current research areas focus on the identification of molecular markers of urologic tumors, adjuvant and neoadjuvant approaches to treatment of aggressive disease, and improved imaging of patients with urologic malignancies.
Mininder S. Kocher
Dr. Kocher is Professor of Orthopedic Surgery and the Associate Director of the Division of Sports Medicine at Boston Children’s Hospital. Clinically, he is an expert in pediatric sports medicine and arthroscopic surgery. His research has focused on outcomes assessment, clinical prediction rules, randomized clinical trials, decision analysis, and health services research.Daniel S. Kohane
Dr. Kohane is Professor of Anesthesia at Children’s Hospital Boston. His expertise is in drug delivery and biomaterials as applied to a wide range of medical conditions as well as tissue engineering and nanomedicine. He is currently a Senior Associate in Pediatric Critical Care at Children’s Hospital Boston at Harvard Medical School, where he directs the Laboratory for Biomaterials and Drug Delivery.
Milton Kotelchuck
Dr. Kotelchuck is Professor of Pediatrics and Senior Scientist in Maternal and Child Health at Mass General Hospital for Children. A nationally prominent Maternal and Child Public Health policy scholar, his research focuses on understanding the role of prenatal and infancy experiences on racial disparities in child health, evaluating the effectiveness of early life clinical interventions and public health programs, developing population-based longitudinal data systems, and translating life course research into practice at the clinical, local, state and national levels.Mary Elizabeth Landrum
Dr. Landrum is Professor of Health Care Policy with specific expertise in Biostatistics. Dr. Landrum’s primary research interests are the development and application of statistical methodology to answer key policy questions for the aging and for the disabled. Dr. Landrum has collaborated on research examining quality of care and its impact on patient outcomes in aging populations, particularly those with cancer.I-Min Lee
Dr. Lee is a recognized leader in the field of physical activity and public health and is Professor of Medicine at Brigham and Women’s Hospital. Her research has focused on the health benefits of physical activity, as well as examined important public health questions related to how much physical activity is required. Her findings have been instrumental in helping to shape current national and international recommendations on physical activity and health.Kent B. Lewandroski
Dr. Lewandrowski is Professor of Pathology, the Director of Pathology Laboratories and Molecular Medicine and Associate Chief of Pathology at the Massachusetts General Hospital. His research interests focus on the evaluation of point-of-care technologies and outcomes studies in critical care settings. He is also editor in chief of the medical journal “Point of Care: The Journal of Near Patient Testing Technologies.
Stuart R. Lipsitz
Dr. Stuart Lipsitz is Professor of Medicine and the Director of Biostatistical Services for the Center for Surgery and Public Health at Brigham and Women’s Hospital. Using his expertise in biostatistics, he has developed a wide assortment of innovative statistical methods, including methods for analyzing complex sample survey data, repeated measures and longitudinal data, and clinical trials. He has applied these biostatistical methods for collaborative research studies in areas such as medical malpractice, medical errors, surgical complications, and health disparities.Dan L. Longo
Dr. Longo is Professor of Medicine in the Division of Hematology at Brigham and Women’s Hospital and Deputy Editor of the New England Journal of Medicine. He has been a leading figure in the treatment of malignant lymphoma including new treatments targeting CD30, CD40, HLA Class II molecules and immunoglobulin idiotype. His laboratory work has focused in part on the regulation of lymphocyte proliferation and NK cell effects on hematopoiesis.Karlen Lyons-Ruth
Dr. Lyons-Ruth is Professor of Psychology in the Department of Psychiatry and is Director of the Biobehavioral Studies Lab at Cambridge Health Alliance. She is a recognized leader in the study of the effects of early trauma, disorganized attachment relationships, maternal depression, and disturbed parent-infant interaction on the later development of psychopathology and neurobiological functioning. A number of assessments for aspects of disturbed attachment relationships, developed in her lab in the context of a 20-year prospective longitudinal study, are now used internationally.Gerassimos M. Makrigiorgos
Dr. Makrigiorgos is Director of the Medical Physics and Biophysics Division of Radiation Oncology and Professor of Radiation Oncology at the Dana Farber Cancer Institute, Brigham and Women’s and Children’s Hospitals. A physicist and biophysicist by training, his research centers on identifying the dosage and effect of radiation on DNA at the cellular and molecular levels and quantifying rare DNA mutations in tumors and clinical samples. He is known as the inventor of cold PCR-based technologies for DNA molecular diagnostics.Edward R. Marcantonio
Dr. Marcantonio is Professor of Medicine and Section Chief for Research in the Division of General Medicine and Primary Care at BIDMC. He is an internationally recognized expert and clinical investigator in the area of delirium (acute confusion), in which he has performed numerous observational and interventional studies. Dr. Marcantonio is the recipient of the HMS A Clifford Barger Award for Excellence in Mentoring and a Mid-Career Investigator Award in Patient-Oriented Research from the National Institute on Aging.Kenneth Mayer
Dr. Mayer is a Professor of Medicine and an Attending Physician and Director of HIV Prevention Research at the Beth Israel Deaconess Medical Center. At Fenway Health in the early 1980’s, he initiated a series of studies of the natural history and prevention of HIV transmission which have been foundational for a series of new interventions assessing how antiretroviral medication can be used for HIV prevention. As the founding Co-Director of The Fenway Institute, he has helped to develop a new center of excellence in community-based research, with a particular focus on sexual and gender minorities, and other underserved populations.Mandeep R. Mehra
Dr. Mehra is Professor of Medicine and Executive Director of the Center for Advanced Heart Disease at the Brigham and Women’s Hospital. He is a leading investigator in the field of Mechanical Circulatory Support and Heart Transplantation with a wide range of investigational activity into biomarkers, novel immunosuppression, translational genomics of allograft rejection and post-transplant coronary artery disease. He is also Editor-in-Chief of The Journal of Heart and Lung Transplantation.Daniel M. Merfeld
Dr. Merfeld is a Professor of Otology and Laryngology as well as Director of the Jenks Vestibular Physiology Laboratory at the Massachusetts Eye and Ear Infirmary. As a neuroscientist, Dr. Merfeld has made fundamental basic science contributions to our understanding of how the brain combines signals from different sensory modalities. As a neuroengineer, Dr. Merfeld has made translational contributions as an inventor of vestibular implants, which provide a treatment option for patients with severe vestibular loss.Rick Mitchell
Dr. Mitchell is a Professor of Pathology and Health Sciences and Technology (HST) at Brigham and Women’s Hospital. His clinical interests in cardiovascular pathology synergize with his basic research concerning the mechanisms underlying acute and chronic cardiac transplant failure. As Associate Director of the HST program and as a long-time educator within the HST curriculum, is known for his teaching and mentoring over a generation of some of our outstanding medical and graduate students.Megan Murray
Dr. Megan Murray is Professor of Global Health and Social Medicine at HMS and Director of Research at the Brigham and Women’s Hospital Division of Global Health Equity. Dr. Murray is recognized as a leader in the field of tuberculosis epidemiology and disease transmission. Her multidisciplinary research focuses on drug resistant TB involving conventional and molecular epidemiology, cost-effectiveness and mathematical modeling, outcomes and operations research, and genomic epidemiology.
George L. Mutter
Dr. Mutter is Professor of Pathology at Brigham and Women’s Hospital, in the Division of Women’s and Perinatal Pathology. His work on endometrial carcinogenesis has illuminated the biologic and morphologic character of premalignant disease, resulting in improved diagnostic criteria that have been implemented in the community. His discovery of “latent precancers” or normal appearing but mutated cells present in the endometrium of most women, links genetic and nongenetic mechanisms of carcinogenesis to suggest novel strategies for cancer prevention.
Anders M. Näär
Dr. Näär is Professor of Cell Biology at Harvard Medical School and Massachusetts General Hospital. His research is focused on elucidating molecular mechanisms of gene regulatory and microRNA control circuits involved in cholesterol/lipid disorders and cardiovascular disease. His discoveries aiding the development of more specific and potent therapeutics for the treatment of cardiometabolic disorders.Harald Paganetti
Dr. Paganetti is Professor of Radiation Oncology and the Director of Physics Research in Radiation Oncology at Massachusetts General Hospital. His research focuses on computer simulations of the dose delivered in radiation therapy and its biological effects to human tissue. He is particularly known for his work on so-called ‘Monte Carlo simulations’ and the relative biological effectiveness of proton beams.Lev T. Perelman
Dr. Perelman is Professor of Obstetrics, Gynecology and Reproductive Biology and Director of the Center for Advanced Biomedical Imaging and Photonics at the Beth Israel Deaconess Medical Center. He is a recognized leader in biomedical optics and cancer detection with light. He pioneered biomedical light scattering spectroscopy which is now a field of biomedical optical imaging.James H. Philip
James Philip MD MEE is Professor of Anaesthesia and Anesthesiologist and Director of Bioengineering in Anesthesia at Brigham and Women’s Hospital. He engineers the medical environment to make it safer, more effective, and less costly. Dr. Philip published and patented what have become successful commercial medical products worldwide. These include continuous cardiac output monitors, CO2 monitors, IV pumps for bolus plus infusion, IV pumps that detect catheter infiltration, constant-pressure infusion systems for fluid resuscitation, and the Gas Man® computer simulation of inhalation anesthetic drug pharmacokinetics for professional education.Kornelia Polyak
Dr. Polyak is an internationally recognized leader in the breast cancer field and Professor of Medicine at Dana-Farber Cancer Institute. Dr. Polyak has been at the forefront of studies employing genomic approaches to study human breast cancer and breast cancer pathogenesis. She was the first to perform comprehensive molecular characterization of all the cell types within a human tumor and determined that gene expression and epigenetic alterations occur in each cell type during tumor progression.Jeffrey J. Popma
Dr. Popma is the Director of Interventional Cardiology Clinical Services at the Beth Israel Deaconess Medical Center and a Professor of Medicine. Over the past 15 years, Dr. Popma has directed over 65 ongoing multicenter device studies. These trials have included a broad array of new technology, including bare metal stents, drug eluting stents, distal protection devices, total occlusion devices, and carotid and peripheral revascularization procedures.Seward Rutkove
Dr. Rutkove is Professor of Neurology at Beth Israel Deaconess Medical Center. His main area of research has been the development of innovative approaches to the non-invasive assessment of neuromuscular disease based on the application of electrical bioimpedance methodologies. The general approach, termed electrical impedance myography, provides a rapid, reproducible and sensitive method for measuring disease status in neuromuscular disorders ranging from amyotrophic lateral sclerosis to muscular dystrophy.Edward T. Ryan
Dr. Ryan is Professor of Medicine and Director of Tropical Medicine at Mass General Hospital. Dr. Ryan is an internationally recognized authority on global infectious diseases, and his laboratory has made critical contributions to the understanding of host-pathogen interactions during intestinal infection, especially cholera and typhoid fever. Dr. Ryan directs a number of university courses on global infectious diseases, directs a Fogarty International Center-NIH Training Program in Global Infectious Diseases, and has served as President of the American Society of Tropical Medicine and Hygiene.Robert Sackstein
Dr. Sackstein is Professor of Dermatology and directs the NIH-designated Program of Excellence in Glycosciences at Harvard Medical School. He is a bone marrow transplant physician and interdisciplinary biomedical scientist whose basic research efforts are focused on resolving therapeutic challenges in the care of bone marrow transplant recipients. He has pioneered the chemical engineering of cell surface sugar structures to program cell migration for clinical applications, including the discovery and structural elucidation of the bone marrow homing molecule “HCELL”.Steven A. Safren
Dr. Safren is a Professor of Psychology in the Department of Psychiatry and Director of Behavioral Medicine at Mass General Hospital. His research has broadly focused on developing and testing cognitive-behavioral interventions for self-care behaviors in medical illness, with a particular focus on HIV and mental health in both domestic and international settings. Additionally, he developed and demonstrated the efficacy of cognitive behavioral therapy for adult ADHD.Paul E. Sax
Dr. Paul E. Sax is Clinical Director of the Division of Infectious Diseases and Professor of Medicine at Brigham and Women’s Hospital. He is internationally recognized as an outstanding clinician and educator in the fields of Infectious Diseases and AIDS. He has also made substantial scholarly contributions to the field through his leadership of several major clinical trials of antiretroviral therapy and studies of cost-effectiveness of HIV treatment.Thomas Scammell
Dr. Scammell is Professor of Neurology at Beth Israel Deaconess Medical Center and is a recognized leader in the study of narcolepsy and other sleep disorders. Work in his lab has identified how loss of the orexin/hypocretin neurons in narcolepsy leads to chronic sleepiness and cataplexy, sudden episodes of muscle weakness triggered by strong emotions. Additional research by his group seeks to define the neural mechanisms that control sleep and wakefulness to foster development of more effective therapies for chronic sleepiness and insomnia.Theodore C. Sectish
Dr. Sectish is Professor of Pediatrics and Program Director of the pediatric residency training program at Children’s Hospital Boston. He is a leader in his discipline as the current Executive Director of the Federation of Pediatric Organizations, an umbrella organization that unites the pediatric academic community in improving child health. He focuses on educational innovation and improvement and is one of the leaders of a multi-site research study to standardize the handoff process to reduce medical errors.Daniel H. Solomon
A rheumatologist and epidemiologist, Dr. Solomon is recognized internationally as a leading expert on the comparative safety and effectiveness of drugs for rheumatic diseases and for his work on cardiovascular complications of rheumatic diseases. He is Professor of Medicine at Brigham and Women’s Hospital, leads the Section of Clinical Sciences in Rheumatology and has mentored over 25 junior faculty in Rheumatology departments worldwide.
Scott D. Solomon
Dr. Solomon is Professor of Medicine and Director of Noninvasive Cardiology at Brigham and Women’s Hospital. His research has focused on the relationship between cardiac structure and function and clinical outcomes, as well as use of cardiac imaging as endpoints in cardiovascular clinical trials. He has led several international trials for novel therapies in post-myocardial infarction and heart failure patients, and also leads the cardiovascular imaging component of the NHLBI sponsored Atherosclerosis Risk in Communities (ARIC) cohort study.Reisa Sperling
Dr. Reisa Sperling is a Professor of Neurology, Director of the Center for Alzheimer Research and Treatment at Brigham and Women’s Hospital and the Harvard Aging Brain Study at Massachusetts General Hospital. She is a leading clinical investigator working on early detection and treatment of Alzheimer’s disease. Her studies span functional and molecular neuroimaging of early AD, cognitive measures to track early decline, and clinical trials of potential disease modifying therapies for AD.John H. Stone
Dr. John H. Stone is a Professor of Medicine and the Clinical Director of Rheumatology at the Massachusetts General Hospital. He has served as the Principal Investigator in NIH-funded, multi-center, international clinical trials in systemic vasculitis that have led to new therapies for those disorders. His work has also led to increased recognition worldwide of an emerging disease known as IgG4-related disease.Peter H. Stone
Dr. Stone is Professor of Medicine at Brigham & Women’s Hospital. He is the Co-Director of the Samuel A. Levine Cardiac Unit and Director of the Vascular Profiling Research Group. His research focuses on the basic pathobiology, as well as the clinical diagnosis and management, of coronary artery disease. He has developed and implemented in-vivo methodologies to identify the detailed characteristics of coronary arterial plaque, the arterial wall, and the local hemodynamic influences affecting the plaque to allow for early identification of high-risk lesions likely to cause a new coronary event.Alphonse Taghian
Dr. Alphonse Taghian is Professor of Radiation Oncology at Massachusetts General Hospital. He is the chief of Breast Radiation Oncology and the co-Director of the Breast Cancer Research Program at MGH Cancer Center. He is internationally known for his technique in Partial Breast Irradiation and his clinical and research interest is focused on lymphedema and quality of life after surviving breast cancer.Ravi Thadhani
Ravi Thadhani, MD, MPH, is Professor of Medicine and Director of Clinical Research in Nephrology at the Massachusetts General Hospital. His work focuses on bringing novel therapies to humans in the areas of Chronic and End Stage Renal Disease and Preeclampsia. He has performed observational studies, first in human studies, and large multinational randomized trials in these areas. He is known internationally for his specific work in the area of altered vitamin D metabolism in kidney disease, and novel first in human studies to treat women with severe preterm preeclampsia.Aristidis Veves
Dr. Aristidis Veves is Professor of Surgery at Beth Israel Deaconess Medical Center and the Research Director of the Joslin-Beth Israel Deaconess Foot Center. His main interest is diabetes complications including cardiovascular disease, neuropathy and foot ulceration. He conducts ‘bench to bedside’ research that focuses on the development of new therapeutic approaches, especially in the area of improving diabetic wound healing.Sean P.J. Whelan
Sean Whelan is Professor of Microbiology and Immunobiology and Associate Head of the Program of Virology. His work has made major contributions to understanding how negative-sense RNA viruses enter cells and express their genetic information. Those viruses include some of the most significant human, animal and plant pathogens extant, for many of which there are no effective antiviral therapeutics or vaccines.Richard I. Whyte
Dr. Whyte is Professor of Surgery and Vice Chair for Clinical Affairs, Quality and Safety for the Department of Surgery at Beth Israel Deaconess Medical Center. Formerly Vice Chair of Cardiothoracic Surgery at Stanford University, Dr. Whyte’s clinical interests are in the management of thoracic malignancies. He has an MBA from the Wharton School of the University of Pennsylvania and has academic interests in health policy and new ways to improve health care quality and delivery.David O. Williams
As a newly appointed member of our faculty, Dr. Williams is a Professor of Medicine and a member of the Division of Cardiovascular Medicine at Brigham and Women’s Hospital. Dr. Williams is a clinician-investigator who was among the first to ever perform coronary angioplasty in the world. He has led several sentinel clinical trials related to coronary artery disease and myocardial infarction, and served on leadership committees for the American Board of Internal Medicine, the American Heart Association and the American College of Cardiology.
Hao Wu
Dr. Hao Wu is a Professor of Biological Chemistry & Molecular Pharmacology and Professor of Pediatrics at Children’s Hospital Boston and has recently joined Harvard from Weill Medical College of Cornell University. She has made important contributions to elucidating the molecular mechanism of immune receptor signal transduction. Her pursuit of the macromolecular interactions in these pathways revealed the formation of high-order signaling assemblies, or “signalosomes”, which are critical for caspase activation, kinase auto-phosphorylation and other oligomerization-driven processes. Her studies challenge the conventional view of signal transduction as a process of successive recruitment and allosteric events.Yi Zhang
Dr. Zhang is a Professor of Genetics and Pediatrics at Harvard Medical School and a Senior Investigator in the Program for Cellular and Molecular Medicine of the Boston Children’s Hospital. Dr. Zhang, a Howard Hughes Investigator, recently joined Harvard Medical School from the University of North Carolina. He is an internationally recognized leader in the field of epigenetics. His lab is responsible for the identification and characterization of several classes of epigenetic enzymes.